OConnell Daniel Joseph

CIK 00018651361 companyNEWTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001865136

Recent Transactions

27 trades

Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-22$1.88/sh−2,689→ 881,275 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-21$1.81/sh−9,346→ 883,964 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2026-01-20+450,000→ 450,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-20+299,800→ 893,310 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-12$1.73/sh−5,388→ 593,510 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-09$1.76/sh−12,941→ 598,898 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-08$1.82/sh−8,143→ 611,839 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-07$1.99/sh−37,755→ 619,982 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-06$1.97/sh−5,102→ 657,737 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2026-01-05$1.97/sh−4,649→ 662,839 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-21$1.59/sh−12,619→ 667,488 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2025-01-07+338,000→ 338,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-07+225,400→ 680,107 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2025-01-03$1.84/sh−47,778→ 454,707 total
Sale
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2024-01-19$3.47/sh−15,200→ 502,485 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2024-01-02+401,000→ 517,685 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2024-01-02+602,000→ 602,000 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2023-01-17+472,500→ 472,500 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2023-01-17+114,000→ 116,685 total
Award
Acumen Pharmaceuticals, Inc.$ABOS
Employee Stock Option (right to buy)
2022-01-19+455,000→ 455,000 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Stock Option (Right to Buy)
2021-11-30−1,118→ 0 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-11-30$4.47/sh+1,118→ 2,685 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Series A Preferred Stock
2021-07-06−123→ 0 total
Tax Payment
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-07-06$16.00/sh−10→ 1,567 total
Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-07-06+123→ 1,542 total
Exercise/Conversion
Acumen Pharmaceuticals, Inc.$ABOS
Warrant (Right to Buy)
2021-07-06−35→ 0 total
Exercise of In-Money
Acumen Pharmaceuticals, Inc.$ABOS
Common Stock
2021-07-06$4.47/sh+35→ 1,577 total

Companies

Acumen Pharmaceuticals, Inc.
Director, Chief Executive Officer
$ABOS

Recent Filings

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465

View on SEC.gov